Fig. 3
From: Real world effectiveness of chemotherapy plus bevacizumab with immunotherapy in colorectal cancer

(A) KM curve of patients with or without liver metastasis. (PFS). (B) KM curve of patients with or without lung metastasis.
From: Real world effectiveness of chemotherapy plus bevacizumab with immunotherapy in colorectal cancer
(A) KM curve of patients with or without liver metastasis. (PFS). (B) KM curve of patients with or without lung metastasis.